Molecular Vision: Jiang, Mol Vis 2024; 30:466-476. Table 2

Table 2. Clinical data of the patients with ARS recruited in our study.

ID	Age (years)	Gender	BCVA (OD/OS)	IOP (OD/OS)	C/D (OD/OS)	AL (OD/OS)	ACD (OD/OS)	CCT (OD/OS)	PAS	pupil	PE	CEC	Glu	Others ocular defect	CA	DA	PU	ECG abnormalities	Others
Patient 1	11	M	HM/CF	43.5/44	1.0/1.0	29.47/26.83	1.99/2.23	729/746	PAS	Corectopia, multiple pupils	PE	1354/-	Glu	esotropia	CA	DA	PU	None	ASD, shortening of the upper labial frenulum, proteinuria
Patient 2	9	F	0.1/0.1	11.6/10.4	0.3/0.4	21.59/22.06	2.47/2.42	696/671	PAS	corectopia	PE	-	None	None	CA	DA	PU	None	ASD, shortening of the upper labial frenulum

Note: F, female; M, male; BCVA, best corrected visual acuity; OD, right eye; OS, left eye; HM, hand movement; CF, counting fingers; IOP, intraocular pressure; C/D, cup-disc ratio; AL, axial length; ACD, anterior chamber depth; CCT, central corneal thickness; PAS, peripheral anterior synechiae; PE, posterior embryotoxon; CEC, corneal endothelial count; Glu, Glaucoma; CA, craniofacial abnormalities; DA, dental abnormalities; PU, protuberant umbilicus; ASD, autism spectrum disorder; –, unknown.